Correlation Between Inozyme Pharma and ArriVent BioPharma,
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and ArriVent BioPharma, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and ArriVent BioPharma, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and ArriVent BioPharma, Common, you can compare the effects of market volatilities on Inozyme Pharma and ArriVent BioPharma, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of ArriVent BioPharma,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and ArriVent BioPharma,.
Diversification Opportunities for Inozyme Pharma and ArriVent BioPharma,
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Inozyme and ArriVent is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and ArriVent BioPharma, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ArriVent BioPharma, and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with ArriVent BioPharma,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ArriVent BioPharma, has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and ArriVent BioPharma, go up and down completely randomly.
Pair Corralation between Inozyme Pharma and ArriVent BioPharma,
Given the investment horizon of 90 days Inozyme Pharma is expected to generate 1.43 times more return on investment than ArriVent BioPharma,. However, Inozyme Pharma is 1.43 times more volatile than ArriVent BioPharma, Common. It trades about 0.06 of its potential returns per unit of risk. ArriVent BioPharma, Common is currently generating about 0.06 per unit of risk. If you would invest 115.00 in Inozyme Pharma on September 14, 2024 and sell it today you would earn a total of 185.00 from holding Inozyme Pharma or generate 160.87% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 45.25% |
| Values | Daily Returns |
Inozyme Pharma vs. ArriVent BioPharma, Common
Performance |
| Timeline |
| Inozyme Pharma |
| ArriVent BioPharma, |
Inozyme Pharma and ArriVent BioPharma, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and ArriVent BioPharma,
The main advantage of trading using opposite Inozyme Pharma and ArriVent BioPharma, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, ArriVent BioPharma, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ArriVent BioPharma, will offset losses from the drop in ArriVent BioPharma,'s long position.| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
| ArriVent BioPharma, vs. Puma Biotechnology | ArriVent BioPharma, vs. Iovance Biotherapeutics | ArriVent BioPharma, vs. Day One Biopharmaceuticals | ArriVent BioPharma, vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |